Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 randomized, double-blind, placebo-controlled study of IkT-148009 in untreated Parkinson disease, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IkT-148009 (IkT-148009)

Snippet

Sponsor: ABLi Therapeutics, Inc. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-11-19